Study to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide.
This is a multi-center long-term open-label non-comparative study to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide. Patients from countries in the EU, the US and Canada who are being treated with lomitapide and are enrolled in The Lomitapide Observational Worldwide Evaluation Registry (LOWER), will be invited by the LOWER enrolling physician to participate in this substudy.
Study Type
OBSERVATIONAL
The percent change from baseline in cartoid vessel wall area at the two-year evaluation
Time frame: 2 years
The percent change from baseline to one and five years on therapy for carotid and aortic vessel wall area, and carotid and aortic vessel wall thickness.
Time frame: 5 Years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.